Ketogenic Diet in Cancer Prevention and Therapy: Molecular Targets and Therapeutic Opportunities.


Journal

Current issues in molecular biology
ISSN: 1467-3045
Titre abrégé: Curr Issues Mol Biol
Pays: Switzerland
ID NLM: 100931761

Informations de publication

Date de publication:
03 Jul 2021
Historique:
received: 02 05 2021
revised: 19 06 2021
accepted: 21 06 2021
entrez: 21 7 2021
pubmed: 22 7 2021
medline: 28 12 2021
Statut: epublish

Résumé

Although cancer is still one of the most significant global challenges facing public health, the world still lacks complementary approaches that would significantly enhance the efficacy of standard anticancer therapies. One of the essential strategies during cancer treatment is following a healthy diet program. The ketogenic diet (KD) has recently emerged as a metabolic therapy in cancer treatment, targeting cancer cell metabolism rather than a conventional dietary approach. The ketogenic diet (KD), a high-fat and very-low-carbohydrate with adequate amounts of protein, has shown antitumor effects by reducing energy supplies to cells. This low energy supply inhibits tumor growth, explaining the ketogenic diet's therapeutic mechanisms in cancer treatment. This review highlights the crucial mechanisms that explain the ketogenic diet's potential antitumor effects, which probably produces an unfavorable metabolic environment for cancer cells and can be used as a promising adjuvant in cancer therapy. Studies discussed in this review provide a solid background for researchers and physicians to design new combination therapies based on KD and conventional therapies.

Identifiants

pubmed: 34287243
pii: cimb43020042
doi: 10.3390/cimb43020042
pmc: PMC8928964
doi:

Substances chimiques

Biomarkers 0

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

558-589

Références

J Agric Food Chem. 2020 Oct 7;68(40):11182-11196
pubmed: 32786841
Aust J Exp Biol Med Sci. 1979 Oct;57(5):529-39
pubmed: 548019
Complement Med Res. 2018;25(2):102-113
pubmed: 29130953
Nature. 2018 Aug;560(7719):499-503
pubmed: 30051890
Science. 2009 Jul 10;325(5937):201-4
pubmed: 19590001
J Gen Physiol. 1927 Mar 7;8(6):519-30
pubmed: 19872213
Rev Endocr Metab Disord. 2020 Dec;21(4):509-519
pubmed: 32514818
Expert Rev Endocrinol Metab. 2015 Jan;10(1):15-24
pubmed: 30289045
Exp Mol Med. 2009 Mar 31;41(3):201-7
pubmed: 19293639
Oncotarget. 2016 Sep 27;7(39):63679-63689
pubmed: 27579768
Front Mol Neurosci. 2016 Nov 16;9:122
pubmed: 27899882
Oncogene. 2011 Oct 6;30(40):4185-93
pubmed: 21625210
Nat Med. 2014 Oct;20(10):1193-1198
pubmed: 25261994
Diabetologia. 2015 Oct;58(10):2414-23
pubmed: 26099854
Biochim Biophys Acta. 2011 Apr;1815(2):135-46
pubmed: 21129444
Epilepsia. 1999 Dec;40(12):1721-6
pubmed: 10612335
Int J Oncol. 2020 Feb;56(2):606-617
pubmed: 31894296
Prostaglandins Other Lipid Mediat. 2019 Oct;144:106338
pubmed: 31100474
Cancer Cell. 2011 May 17;19(5):613-28
pubmed: 21575862
Nutr Metab (Lond). 2011 Oct 26;8:75
pubmed: 22029671
Br J Cancer. 2003 Oct 6;89(7):1375-82
pubmed: 14520474
Curr Opin Clin Nutr Metab Care. 2018 Jul;21(4):260-266
pubmed: 29697540
J Cell Biochem. 2016 Mar;117(3):574-88
pubmed: 26251955
Int J Radiat Biol. 2009 Nov;85(11):963-71
pubmed: 19895273
J Cancer Prev. 2017 Sep;22(3):127-134
pubmed: 29018777
Cancer Res. 2009 Oct 15;69(20):7986-93
pubmed: 19826036
Nat Rev Cancer. 2009 Oct;9(10):749-58
pubmed: 19776744
Acta Biochim Pol. 2012;59(4):467-74
pubmed: 23173124
Oncotarget. 2015 Jun 10;6(16):14545-55
pubmed: 26036630
J Child Neurol. 1995 Nov;10(6):419-23
pubmed: 8576550
Prog Growth Factor Res. 1992;4(2):121-37
pubmed: 1338573
J Neurooncol. 2021 Jul;153(3):487-496
pubmed: 34152528
Curr Colorectal Cancer Rep. 2012 Mar;8(1):66-81
pubmed: 22389639
Nutrients. 2018 Aug 30;10(9):
pubmed: 30200193
Trends Cancer. 2017 Mar;3(3):169-180
pubmed: 28393116
Cell Death Dis. 2012 Jan 12;3:e248
pubmed: 22237205
Biomolecules. 2020 May 05;10(5):
pubmed: 32380782
Clin Cancer Res. 2017 Oct 15;23(20):6292-6304
pubmed: 28720668
Science. 1998 Jan 23;279(5350):563-6
pubmed: 9438850
Proc Natl Acad Sci U S A. 2017 Jan 3;114(1):125-130
pubmed: 27999180
Adv Pediatr. 1997;44:297-329
pubmed: 9265974
Curr Pharm Des. 2017;23(25):3629-3644
pubmed: 28714409
Mediators Inflamm. 2016;2016:8319283
pubmed: 27610006
Proc Natl Acad Sci U S A. 2016 Nov 22;113(47):E7535-E7544
pubmed: 27821766
Oncotarget. 2017 Jan 24;8(4):6540-6554
pubmed: 28029661
Nature. 2008 Mar 13;452(7184):230-3
pubmed: 18337823
Cancer Prev Res (Phila). 2010 Sep;3(9):1124-31
pubmed: 20716631
Front Cell Dev Biol. 2020 Feb 28;8:71
pubmed: 32185171
Eur J Med Chem. 2020 May 15;194:112260
pubmed: 32224379
Sci Rep. 2016 Feb 19;6:21807
pubmed: 26892894
Nucleic Acids Res. 2016 May 5;44(8):3865-77
pubmed: 26921406
PLoS One. 2014 Sep 25;9(9):e108444
pubmed: 25254953
Clin Nutr. 2021 Jun;40(6):4267-4274
pubmed: 33551218
Curr Treat Options Neurol. 2008 Nov;10(6):410-9
pubmed: 18990309
Sci Rep. 2019 Oct 29;9(1):15529
pubmed: 31664147
Anticancer Res. 2015 Oct;35(10):5525-32
pubmed: 26408720
J Clin Invest. 2014 Jan;124(1):30-9
pubmed: 24382387
Cancer. 2011 Jan 1;117(1):86-95
pubmed: 20737575
Semin Cancer Biol. 2021 Aug;73:30-44
pubmed: 32977005
Exp Neurol. 2011 Dec;232(2):195-202
pubmed: 21939657
BMC Cancer. 2016 Oct 3;16(1):764
pubmed: 27716121
Trends Biochem Sci. 2016 Mar;41(3):211-218
pubmed: 26778478
Adv Clin Exp Med. 2017 May-Jun;26(3):421-426
pubmed: 28791816
Nutr Metab (Lond). 2010 Sep 10;7:74
pubmed: 20831808
J Physiol. 2006 Jul 1;574(Pt 1):63-71
pubmed: 16613876
Clinics (Sao Paulo). 2018 Dec 10;73(suppl 1):e814s
pubmed: 30540126
J Lifestyle Med. 2021 Jan 31;11(1):1-7
pubmed: 33763336
Biomed Res Int. 2020 Aug 4;2020:8105735
pubmed: 32802877
Mol Diagn Ther. 2020 Apr;24(2):153-173
pubmed: 32067191
Exp Suppl. 2016;107:203-226
pubmed: 27812982
Oncogene. 2010 Feb 11;29(6):781-8
pubmed: 19946329
Nutr Cancer. 2020;72(4):627-634
pubmed: 31496287
J Mol Diagn. 2010 Jul;12(4):433-40
pubmed: 20413677
Cancers (Basel). 2015 Nov 23;7(4):2309-17
pubmed: 26610570
Clin Nutr. 2021 Mar;40(3):751-758
pubmed: 32703721
Int J Mol Sci. 2019 May 22;20(10):
pubmed: 31121868
Oncol Lett. 2018 Jan;15(1):1263-1270
pubmed: 29391903
Mol Biol Rep. 2015 Apr;42(4):841-51
pubmed: 25689954
Expert Rev Mol Med. 2019 Sep 27;21:e4
pubmed: 31558177
BMC Cancer. 2009 Oct 20;9:374
pubmed: 19843336
Science. 1956 Aug 10;124(3215):270-2
pubmed: 13351640
Cancers (Basel). 2011 Mar 03;3(1):994-1013
pubmed: 24212651
Expert Rev Mol Diagn. 2020 Jan;20(1):19-30
pubmed: 31747311
Front Med (Lausanne). 2020 Jan 31;7:7
pubmed: 32083086
PLoS One. 2015 Jul 20;10(7):e0133633
pubmed: 26192445
BJU Int. 2012 Oct;110(7):1062-9
pubmed: 22394625
PLoS One. 2014 Dec 11;9(12):e115147
pubmed: 25502434
PLoS One. 2015 Jun 17;10(6):e0130357
pubmed: 26083629
SAGE Open Med. 2020 Jun 1;8:2050312120926877
pubmed: 32537159
Epigenomics. 2011 Oct;3(5):581-609
pubmed: 22126248
Carcinogenesis. 2010 Jan;31(1):37-49
pubmed: 19955394
Cancers (Basel). 2014 Feb 10;6(1):366-75
pubmed: 24518611
Med Oncol. 2017 Aug;34(8):132
pubmed: 28653283
Cell Oncol (Dordr). 2020 Feb;43(1):1-18
pubmed: 31900901
Urology. 2006 Jul;68(1):15-8
pubmed: 16844447
Biol Pharm Bull. 2006 May;29(5):903-6
pubmed: 16651716
Prostate Cancer Prostatic Dis. 2017 Jun;20(2):165-171
pubmed: 28244492
Biochem Biophys Res Commun. 2014 Jan 17;443(3):789-95
pubmed: 24275137
Redox Biol. 2014;2:963-70
pubmed: 25460731
J Lipid Res. 2018 Apr;59(4):625-634
pubmed: 29414764
Cancer Res. 2006 Aug 1;66(15):7390-4
pubmed: 16885332
N Engl J Med. 2018 Nov 22;379(21):2052-2062
pubmed: 30462943
J Cell Biol. 2020 Jan 6;219(1):
pubmed: 31690618
Eur J Surg Oncol. 2011 Jul;37(7):597-603
pubmed: 21546206
Front Nutr. 2021 Feb 25;8:634845
pubmed: 33718419
BMC Cancer. 2008 Apr 30;8:122
pubmed: 18447912
Cancer Prev Res (Phila). 2009 Jun;2(6):557-65
pubmed: 19470786
Ann N Y Acad Sci. 2011 Jul;1229:45-52
pubmed: 21793838
Cell. 2017 Mar 9;168(6):960-976
pubmed: 28283069
Dev Med Child Neurol. 2001 May;43(5):301-6
pubmed: 11368482
J Nutr. 2018 Aug 1;148(8):1253-1260
pubmed: 30137481
Int J Cancer. 2014 Apr 15;134(8):1926-34
pubmed: 24122631
J Hepatol. 2010 Jul;53(1):98-107
pubmed: 20447717
Clin Nutr. 2020 Dec;39(12):3637-3644
pubmed: 32340904
J Hepatol. 2012 Jan;56(1):167-75
pubmed: 21749846
Annu Rev Physiol. 2010;72:219-46
pubmed: 20148674
BioDrugs. 2007;21(2):97-104
pubmed: 17402793
World J Gastroenterol. 2010 Mar 28;16(12):1500-5
pubmed: 20333791
Amino Acids. 2011 Nov;41(5):1185-93
pubmed: 21773813
Biochemistry (Mosc). 2019 Oct;84(10):1117-1128
pubmed: 31694508
Front Nutr. 2020 Mar 11;7:21
pubmed: 32219096
Nutr Metab (Lond). 2010 Jan 27;7:7
pubmed: 20181022
Clin Nutr. 1991 Aug;10(4):228-32
pubmed: 16839923
Carcinogenesis. 2014 Mar;35(3):515-27
pubmed: 24343361
Curr Opin Neurol. 2017 Apr;30(2):187-192
pubmed: 28141738
Biochim Biophys Acta Rev Cancer. 2018 Aug;1870(1):1
pubmed: 30336841
Cancers (Basel). 2020 Jul 29;12(8):
pubmed: 32751207
Curr Pharmacol Rep. 2015 Jun 1;1(3):141-153
pubmed: 26029495
Adv Nutr. 2015 May 15;6(3):293S-301S
pubmed: 25979502
Chemotherapy. 2020;65(3-4):77-84
pubmed: 33197913
Cancer Lett. 2015 Jan 28;356(2 Pt A):184-91
pubmed: 24508027
Fed Pract. 2017 Feb;34(Suppl 1):37S-42S
pubmed: 30766299
Cell Metab. 2017 Feb 7;25(2):358-373
pubmed: 28089569
Support Care Cancer. 2021 May;29(5):2299-2304
pubmed: 33190181
Microrna. 2019;8(2):116-126
pubmed: 30474543
Amino Acids. 2018 Dec;50(12):1685-1695
pubmed: 30167963
Cell Res. 2011 Jan;21(1):159-68
pubmed: 21187858
Science. 2015 Jan 9;347(6218):194-8
pubmed: 25567907
Epilepsia. 1992 Nov-Dec;33(6):1132-6
pubmed: 1464275
Int J Hyperthermia. 2019;36(1):446-455
pubmed: 30931666
Nature. 2012 Aug 30;488(7413):569
pubmed: 22932356
PLoS One. 2013 Jul 24;8(7):e68543
pubmed: 23894315
Mol Cell. 2020 Jun 18;78(6):1034-1044
pubmed: 32504556
Genes Dev. 2012 Jun 15;26(12):1268-86
pubmed: 22713868
Curr Opin Clin Nutr Metab Care. 2019 Mar;22(2):129-134
pubmed: 30531479
J Neurooncol. 2014 Mar;117(1):125-31
pubmed: 24442482
J Transl Med. 2016 May 20;14(1):143
pubmed: 27197967
Mol Carcinog. 2012 Mar;51(3):213-30
pubmed: 21739482
Int J Oncol. 2009 Sep;35(3):547-57
pubmed: 19639175
Biochem Pharmacol. 2006 Nov 30;72(11):1605-21
pubmed: 16889756
Nat Rev Cancer. 2016 Oct;16(10):650-62
pubmed: 27634448
Cancer Res. 1989 Jul 15;49(14):3800-4
pubmed: 2736521
Cancer Metastasis Rev. 2020 Sep;39(3):837-886
pubmed: 32577859
JCI Insight. 2021 Jan 25;6(2):
pubmed: 33320838
PLoS One. 2012;7(5):e36197
pubmed: 22563484
J Nucl Med. 2008 Jun;49 Suppl 2:24S-42S
pubmed: 18523064
Jpn Dent Sci Rev. 2018 Feb;54(1):8-21
pubmed: 29628997
J Hepatol. 2015 Mar;62(3):599-606
pubmed: 25450719
Mol Metab. 2020 Mar;33:102-121
pubmed: 31399389
J Biomed Sci. 2017 Dec 04;24(1):90
pubmed: 29202842
Mol Cell Oncol. 2020 Jul 29;7(5):1791671
pubmed: 32944646
Am J Physiol Endocrinol Metab. 2006 Aug;291(2):E381-7
pubmed: 16507602
J Clin Pathol. 2020 Dec;73(12):826-829
pubmed: 32376713
J Nutr. 2020 Jun 1;150(6):1354-1359
pubmed: 31825066
Hepatol Res. 2017 Feb;47(2):149-159
pubmed: 27457249
Oncotarget. 2017 Jul 17;8(34):57201-57215
pubmed: 28915665
Int J Oncol. 2014 Jun;44(6):1843-52
pubmed: 24728273
BMC Cancer. 2011 Jul 26;11:315
pubmed: 21791085
Radiat Res. 2017 Jun;187(6):743-754
pubmed: 28437190
Mol Cancer Res. 2011 Mar;9(3):294-310
pubmed: 21257818
Cancers (Basel). 2020 Jul 13;12(7):
pubmed: 32668598
FEBS Lett. 2011 Apr 20;585(8):1191-6
pubmed: 21439283
Front Nutr. 2018 Mar 29;5:20
pubmed: 29651419
Br J Cancer. 1989 May;59(5):677-81
pubmed: 2736199
J Clin Invest. 2011 Jul;121(7):2679-83
pubmed: 21701065
Cancer J. 2015 Mar-Apr;21(2):49-55
pubmed: 25815843
Cell Metab. 2019 Jan 8;29(1):192-201.e7
pubmed: 30197302
Adv Exp Med Biol. 2015;860:187-93
pubmed: 26303480
J Clin Oncol. 2017 Jul 1;35(19):2184-2192
pubmed: 28489511
J Neurooncol. 2017 Apr;132(2):267-275
pubmed: 28074323
Cancers (Basel). 2021 Feb 24;13(5):
pubmed: 33668153
Arch Neurol. 1998 Nov;55(11):1433-7
pubmed: 9823827
RNA Biol. 2011 Sep-Oct;8(5):706-13
pubmed: 21712654
Trends Mol Med. 2014 Aug;20(8):419-27
pubmed: 24916302
J Am Coll Nutr. 1995 Apr;14(2):202-8
pubmed: 7790697
J Clin Biochem Nutr. 2019 May;64(3):201-208
pubmed: 31138953
Chin Med Sci J. 2012 Jun;27(2):65-72
pubmed: 22770403
Exp Dermatol. 2012 Jul;21(7):509-14
pubmed: 22716245
Nutr Cancer. 2018 May-Jun;70(4):643-649
pubmed: 29668317
Cancer Res. 2014 Dec 1;74(23):6991-7002
pubmed: 25304261
Cells. 2020 Jan 23;9(2):
pubmed: 31979244
FEBS Open Bio. 2020 May;10(5):752-760
pubmed: 32090490
Nutr Metab (Lond). 2011 Jul 27;8(1):54
pubmed: 21794124
J Biol Chem. 2007 May 11;282(19):14328-36
pubmed: 17363372
CA Cancer J Clin. 2020 Nov;70(6):443-459
pubmed: 32940362
J Food Biochem. 2020 Mar;44(3):e13140
pubmed: 31943235
Neurooncol Pract. 2015 Sep;2(3):127-136
pubmed: 26649186
Cureus. 2017 Jul 7;9(7):e1445
pubmed: 28924531
Virchows Arch. 1994;424(2):177-85
pubmed: 8180780
Br J Cancer. 1987 Jul;56(1):39-43
pubmed: 3620317
Clin Cancer Res. 2013 Jul 15;19(14):3905-13
pubmed: 23743570
Oncotarget. 2015 Apr 10;6(10):7365-78
pubmed: 25812084
Cell. 2010 Mar 19;140(6):883-99
pubmed: 20303878
Adv Exp Med Biol. 2018;1063:13-32
pubmed: 29946773
Cell Death Dis. 2019 Mar 11;10(3):243
pubmed: 30858356
Front Physiol. 2015 Dec 16;6:382
pubmed: 26733270
Clin Cancer Res. 2014 Jun 15;20(12):3319-27
pubmed: 24727325
Neurosci Lett. 2018 Sep 14;683:13-18
pubmed: 29894768
Nat Rev Clin Oncol. 2015 Oct;12(10):584-96
pubmed: 26122183
Breast Cancer Res Treat. 2003 Aug;80(3):245-55
pubmed: 14503797
Commun Biol. 2019 May 29;2:200
pubmed: 31149644
J Lipid Res. 2015 Jan;56(1):5-10
pubmed: 24503133
Nutr Cancer. 2013;65(6):843-9
pubmed: 23909728
Nutrients. 2018 Feb 14;10(2):
pubmed: 29443873
Br J Cancer. 2019 Feb;120(3):340-345
pubmed: 30636774
Cancer Metab. 2014 Sep 01;2:18
pubmed: 25228990
Nutr Cancer. 2008;60(1):61-8
pubmed: 18444137
Nutrients. 2020 Mar 17;12(3):
pubmed: 32192146
Prostate. 2008 Jan 1;68(1):11-9
pubmed: 17999389
J Radiat Oncol. 2016 Sep;5(3):279-286
pubmed: 27746859
Sci Adv. 2016 May 27;2(5):e1600200
pubmed: 27386546
Nat Rev Cancer. 2018 Nov;18(11):707-719
pubmed: 30327499
AAPS J. 2009 Dec;11(4):682-92
pubmed: 19842044
Nat Rev Mol Cell Biol. 2017 Feb;18(2):90-101
pubmed: 27924077
Dis Markers. 2014;2014:494581
pubmed: 24864130
Cancer Med. 2016 Aug;5(8):1917-46
pubmed: 27282910
Cancers (Basel). 2018 Sep 05;10(9):
pubmed: 30189621
Oncol Res Treat. 2015;38(3):117-22
pubmed: 25792083

Auteurs

Wamidh H Talib (WH)

Department of Clinical Pharmacy and Therapeutics, Applied Science Private University, Amman 11931, Jordan.

Asma Ismail Mahmod (AI)

Department of Clinical Pharmacy and Therapeutics, Applied Science Private University, Amman 11931, Jordan.

Ayah Kamal (A)

Department of Clinical Pharmacy and Therapeutics, Applied Science Private University, Amman 11931, Jordan.

Hasan M Rashid (HM)

Department of Clinical Pharmacy and Therapeutics, Applied Science Private University, Amman 11931, Jordan.

Aya M D Alashqar (AMD)

Department of Clinical Pharmacy and Therapeutics, Applied Science Private University, Amman 11931, Jordan.

Samar Khater (S)

Department of Clinical Pharmacy and Therapeutics, Applied Science Private University, Amman 11931, Jordan.

Duaa Jamal (D)

Department of Clinical Pharmacy and Therapeutics, Applied Science Private University, Amman 11931, Jordan.

Mostafa Waly (M)

Department of Food Science and Nutrition, College of Agricultural and Marine Sciences, Sultan Qaboos University, Al-Khoud 34-123, Oman.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH